Saturday 17 October 2026
Export EDSA’s income statement to Excel — free account
Edesa Biotech, Inc.
EDSA Healthcare Biotechnology
In the quarter to June 2026, EPS fell 140.0% and free cash flow fell 81.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.57
0.10
−3.75%
Follow EDSA
| Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | Sep '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | 3 | 4 | 4 | 3 | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
P/S ratio |
16.65 | 51.09 | 18.56 | 53.95 | 211.30 | — | — | — | — | — |
Altman Z-Score |
15.91 | 12.18 | (1.51) | 38.67 | 22.29 | — | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
13.83 | 5.96 | 12.83 | 10.73 | 1.81 | — | — | — | — | — |
P/Operating CF |
(17.76) | (10.44) | (1.02) | (10.06) | (41.53) | — | — | — | — | — |
Beneish M-Score |
(2.07) | — | — | (0.10) | (4.36) | — | — | — | — | — |
P/B ratio |
1.72 | 1.58 | 0.35 | 5.97 | 10.48 | — | — | — | — | — |
Price to Tangible BV |
1.72 | 1.58 | 0.35 | 5.97 | 16.75 | — | — | — | — | — |
EV/Sales |
7.68 | 22.33 | (29.41) | 45.30 | 189.37 | — | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 1.29 | 0.00 | 0.00 | — | — | — | — | — |
EV/Operating CF |
(2.17) | (1.08) | 1.37 | (3.37) | (12.49) | — | — | — | — | — |
EV/FCF |
(1.99) | (1.02) | 1.26 | (3.22) | (12.61) | — | — | — | — | — |
Quick Ratio |
18.43 | 20.46 | 20.97 | 11.37 | 4.77 | 7.64 | 3.90 | 3.29 | 0.71 | 10.60 |
Current Ratio |
19.40 | 21.06 | 21.60 | 12.23 | 5.30 | 8.29 | 4.25 | 3.53 | 0.91 | 10.67 |
Net Debt/EBITDA |
2.40 | 1.30 | 2.11 | 1.78 | 1.14 | 0.33 | 0.39 | 0.59 | 0.15 | 1.39 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.11 | 0.02 | 0.02 | 0.05 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.90 | 0.93 | 0.92 | 1.75 | 0.78 | 1.02 | 0.70 | 0.79 | 0.79 | 1.02 |
Capex/Depreciation |
(2.69) | (1.69) | (2.03) | 0.00 | 0.33 | (0.05) | (0.05) | 0.00 | 0.00 | 0.00 |
| (49.47%) | (51.04%) | (53.93%) | (33.57%) | (107.08%) | (135.54%) | (156.34%) | (101.88%) | (136.66%) | (277.81%) | |
| (43.10%) | (48.70%) | (51.68%) | (31.74%) | (77.23%) | (105.28%) | (134.16%) | (81.84%) | (97.13%) | (82.86%) | |
ROIC |
(337.67%) | (391.67%) | (322.88%) | (784.95%) | (211.18%) | (283.59%) | (499.12%) | (341.61%) | (464.48%) | (297.91%) |
Return on Tangible Assets |
(41.09%) | (68.75%) | (44.89%) | (52.83%) | (96.59%) | (125.32%) | (252.00%) | (181.12%) | 3,924.94% | (68.86%) |
Average Days of Receivables |
24.63 | 2.08 | 71.00 | 192.85 | 97.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
135.99% | 864.39% | 985.55% | 266.83% | 1,012.62% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
261.29% | 1,289.97% | 1,301.89% | 497.76% | 1,028.77% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.23 | 0.16 | 0.20 | 0.25 | 0.55 | 0.15 |
Share Based Compensation of Revenue |
20.40% | 50.59% | 72.85% | 0.00% | 182.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.54 | 0.55 | 2.55 | 0.17 | 0.09 | — | — | — | — | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Earnings Yield |
(23.31%) | (100.99%) | (124.69%) | (10.36%) | (9.17%) | — | — | — | — | — |
Free Cash Flow Yield |
(23.19%) | (42.89%) | (125.35%) | (26.11%) | (7.11%) | — | — | — | — | — |
Revenue per Share |
42.39 | 6.56 | 3.10 | 0.57 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(150.19) | (135.05) | (67.58) | (6.73) | (4.05) | (7.92) | (5.86) | (2.32) | (1.53) | (1.29) |
Capex per Share |
(13.41) | (8.70) | (5.60) | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(163.60) | (143.74) | (73.18) | (6.73) | (4.04) | (7.92) | (5.86) | (2.32) | (1.53) | (1.29) |
Cash per Share |
380.19 | 188.66 | 150.86 | 6.99 | 5.87 | 4.54 | 3.38 | 1.88 | 0.32 | 1.90 |
Shareholders Equity per Share |
410.47 | 212.62 | 165.25 | 7.30 | 7.41 | 7.57 | 4.48 | 2.47 | 0.62 | 2.19 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
410.47 | 212.62 | 165.25 | 7.30 | 7.41 | 7.57 | 4.48 | 2.47 | 0.62 | 2.19 |
Free Cash Flow |
(4.91) | (5.00) | (5.00) | (4.85) | (4.97) | (13.67) | (12.28) | (6.64) | (4.89) | (7.32) |
Working Capital |
11.48 | 6.44 | 10.16 | 5.18 | 6.57 | 10.63 | 6.95 | 4.62 | (0.16) | 10.43 |
Capital Expenditures |
(0.40) | (0.30) | (0.38) | (0.01) | 0.02 | (0.01) | (0.01) | — | — | — |
Net Current Asset Value |
11.48 | 6.44 | 10.16 | 5.18 | 6.45 | 10.56 | 6.91 | 4.60 | (0.16) | 10.43 |
EV/EBIT |
0.00 | 0.00 | 1.24 | 0.00 | 0.00 | — | — | — | — | — |
Capex to Sales |
0.32 | 1.33 | 1.81 | 0.00 | (0.06) | 0.00 | 0.00 | — | — | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.20 | 0.20 | 0.18 | 0.07 | 3.89 | 7.92 | 9.31 | 21.09 | 0.00 | 0.00 |
Cash ROIC |
(20.69%) | (35.82%) | (23.15%) | (47.11%) | (30.43%) | (65.42%) | (74.53%) | (53.48%) | (162.01%) | (31.50%) |
Accounts Receivable Turnover |
10.45 | 5.24 | 9.97 | 3.18 | 2.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
1.76 | 1.13 | 1.09 | 0.21 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
2.80 | 3.37 | 3.05 | 0.67 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Average Days of Payables |
201.82 | 219.14 | 404.43 | 1,663.22 | 30,280.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
80.72 | 46.50 | 183.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Average Receivables |
0.12 | 0.04 | 0.02 | 0.13 | 0.15 | 1.70 | 2.28 | 0.94 | 0.45 | 0.46 |
Average Payables |
0.64 | 0.47 | 0.41 | 0.48 | 0.96 | 1.42 | 1.75 | 1.93 | 1.78 | 1.45 |
Average Inventory |
0.40 | 0.16 | 0.15 | 0.15 | — | — | — | — | — | — |
Average Assets |
11.66 | 10.33 | 9.75 | 8.75 | 8.24 | 12.67 | 13.08 | 10.23 | 6.35 | 8.67 |
Average Common Equity |
10.16 | 9.86 | 9.34 | 8.27 | 5.94 | 9.84 | 11.22 | 8.22 | 4.52 | 2.59 |
Columns are period end dates